SPECTRAL AI INC (MDAI) Fundamental Analysis & Valuation

NASDAQ:MDAI • US84757T1051

Current stock price

1.84 USD
+0.04 (+2.22%)
At close:
1.8488 USD
+0.01 (+0.48%)
After Hours:

This MDAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MDAI Profitability Analysis

1.1 Basic Checks

  • MDAI had negative earnings in the past year.
  • In the past year MDAI has reported a negative cash flow from operations.
  • MDAI had negative earnings in 4 of the past 5 years.
  • In the past 5 years MDAI always reported negative operating cash flow.
MDAI Yearly Net Income VS EBIT VS OCF VS FCFMDAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 10M -10M -20M

1.2 Ratios

  • The Return On Assets of MDAI (-35.37%) is worse than 60.43% of its industry peers.
Industry RankSector Rank
ROA -35.37%
ROE N/A
ROIC N/A
ROA(3y)-119.01%
ROA(5y)-32.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDAI Yearly ROA, ROE, ROICMDAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 500 -500 1K

1.3 Margins

  • The Gross Margin of MDAI (45.42%) is worse than 60.43% of its industry peers.
  • MDAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MDAI Yearly Profit, Operating, Gross MarginsMDAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. MDAI Health Analysis

2.1 Basic Checks

  • MDAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for MDAI has been increased compared to 1 year ago.
  • MDAI has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for MDAI is higher compared to a year ago.
MDAI Yearly Shares OutstandingMDAI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M
MDAI Yearly Total Debt VS Total AssetsMDAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • MDAI has an Altman-Z score of -2.83. This is a bad value and indicates that MDAI is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -2.83, MDAI is not doing good in the industry: 66.84% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.83
ROIC/WACCN/A
WACC8.2%
MDAI Yearly LT Debt VS Equity VS FCFMDAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • MDAI has a Current Ratio of 0.94. This is a bad value and indicates that MDAI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of MDAI (0.94) is worse than 91.98% of its industry peers.
  • MDAI has a Quick Ratio of 0.94. This is a bad value and indicates that MDAI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MDAI has a worse Quick ratio (0.90) than 83.96% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.9
MDAI Yearly Current Assets VS Current LiabilitesMDAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MDAI Growth Analysis

3.1 Past

  • MDAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.10%, which is quite impressive.
  • MDAI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.57%.
EPS 1Y (TTM)63.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
Revenue 1Y (TTM)-33.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.69% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -0.33% on average over the next years.
EPS Next Y-59.03%
EPS Next 2Y-33.71%
EPS Next 3Y41.87%
EPS Next 5Y35.69%
Revenue Next Year1.94%
Revenue Next 2Y12.2%
Revenue Next 3Y19.98%
Revenue Next 5Y-0.33%

3.3 Evolution

MDAI Yearly Revenue VS EstimatesMDAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
MDAI Yearly EPS VS EstimatesMDAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 -0.5 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. MDAI Valuation Analysis

4.1 Price/Earnings Ratio

  • MDAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MDAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDAI Price Earnings VS Forward Price EarningsMDAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDAI Per share dataMDAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

  • MDAI's earnings are expected to grow with 41.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.71%
EPS Next 3Y41.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MDAI Dividend Analysis

5.1 Amount

  • No dividends for MDAI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MDAI Fundamentals: All Metrics, Ratios and Statistics

SPECTRAL AI INC

NASDAQ:MDAI (4/24/2026, 8:00:01 PM)

After market: 1.8488 +0.01 (+0.48%)

1.84

+0.04 (+2.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-24
Earnings (Next)05-12
Inst Owners12%
Inst Owner Change0%
Ins Owners11.49%
Ins Owner Change0%
Market Cap58.55M
Revenue(TTM)19.65M
Net Income(TTM)-7.57M
Analysts85
Price Target5.47 (197.28%)
Short Float %5.38%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)31.27%
Min EPS beat(2)-52.95%
Max EPS beat(2)115.48%
EPS beat(4)2
Avg EPS beat(4)-17.24%
Min EPS beat(4)-314.46%
Max EPS beat(4)182.96%
EPS beat(8)4
Avg EPS beat(8)-28.18%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.05%
Min Revenue beat(2)-25.01%
Max Revenue beat(2)29.12%
Revenue beat(4)2
Avg Revenue beat(4)4.9%
Min Revenue beat(4)-25.01%
Max Revenue beat(4)29.12%
Revenue beat(8)5
Avg Revenue beat(8)5.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-350%
EPS NQ rev (3m)-350%
EPS NY rev (1m)19.89%
EPS NY rev (3m)19.89%
Revenue NQ rev (1m)-4.28%
Revenue NQ rev (3m)-4.28%
Revenue NY rev (1m)34.1%
Revenue NY rev (3m)34.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.98
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.62
BVpS-0.18
TBVpS-0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -35.37%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.42%
FCFM N/A
ROA(3y)-119.01%
ROA(5y)-32.15%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.9
Altman-Z -2.83
F-Score3
WACC8.2%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.88%
EPS Next Y-59.03%
EPS Next 2Y-33.71%
EPS Next 3Y41.87%
EPS Next 5Y35.69%
Revenue 1Y (TTM)-33.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.38%
Revenue Next Year1.94%
Revenue Next 2Y12.2%
Revenue Next 3Y19.98%
Revenue Next 5Y-0.33%
EBIT growth 1Y-30.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.09%
EBIT Next 3Y31.09%
EBIT Next 5Y30.25%
FCF growth 1Y-7.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.84%
OCF growth 3YN/A
OCF growth 5YN/A

SPECTRAL AI INC / MDAI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SPECTRAL AI INC?

ChartMill assigns a fundamental rating of 1 / 10 to MDAI.


What is the valuation status for MDAI stock?

ChartMill assigns a valuation rating of 1 / 10 to SPECTRAL AI INC (MDAI). This can be considered as Overvalued.


What is the profitability of MDAI stock?

SPECTRAL AI INC (MDAI) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for MDAI stock?

The Earnings per Share (EPS) of SPECTRAL AI INC (MDAI) is expected to decline by -59.03% in the next year.